Nephro Care India was incorporated on July 8, 2014. The company was founded with the objective of providing comprehensive medical services for renal patients. Based in Kolkata, it is a one-stop treatment center offering a wide range of clinical and lifestyle solutions and services for renal insufficiency treatment.
| Bidding Dates |
|---|
| 28 Jun 2024 - 02 Jul 2024 |
| Subscription |
|---|
| 666.56x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,36,000 | 1 | 1 | 1600 | 4.6 M | ₹85 - ₹90 | 61.38 % | ₹389.6 M - ₹412.6 M | RHP DOC |
Nephro Care IPO SUBSCRIPTION STATUS
02 Jul '24Nephro Care IPO overall subscription rate was 666.56 times the total available shares
Nephro Care IPO retail subscription rate was 782.41 times in the retail segment
Nephro Care IPO non-institutional investor subscription rate was 2214.78 times in the non-institutional investor category
Nephro Care IPO Qualified Institutional Bidder subscription rate was 120.99 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
02 Jul 2024 (Day 3) | 782.41x | 2214.78x | 120.99x |
01 Jul 2024 (Day 2) | 252.14x | 256.48x | 1.32x |
28 Jun 2024 (Day 1) | 36.11x | 17.72x | 0.04x |
Nephro Care FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| 9MFY24 | 34.0 | 197.5 | 17.2 | 16.7 | 25.6% |
| FY23 | 19.4 | 170.9 | 43.1 | 37.6 | 21.3% |
| FY22 | -0.1 | 34.2 | 6.2 | -8.3 | 3.7% |
| FY21 | 0.9 | 18.2 | 2.3 | 1.6 | 8.5% |
Nephro Care IPO SUBSCRIPTION STATUS DETAILS
Nephro Care had 4.6 M shares on offer
Nephro Care IPO offer price was in the range ₹85 - ₹90
Nephro Care IPO minimum Investment was ₹136000
Nephro Care IPO issue size was ₹ 389.6 M - ₹ 412.6 M
Nephro Care had a minimum lot size of 1600 Shares per application
Nephro Care NUMBER OF SHARES ON OFFER
Nephro Care IPO IMPORTANT DATES
| Issue Open Date | 28 Jun 2024 |
| Issue close Date | 02 Jul 2024 |
| Allotment Date | 03 Jul 2024 |
| Refund Date | 04 Jul 2024 |
| Demat Account Credit Date | 04 Jul 2024 |
| Listing Date | 05 Jul 2024 |
| Listing on Exchange(s) | NSE |
| Nephro Care Allotment Status | Exchange |
Nephro Care IPO subscription opened on 28 Jun 2024, and closed on 02 Jul 2024
IPO allotment for Nephro Care was finalized on Wednesday, 03 Jul 2024
IPO listing for Nephro Care was on NSE on Friday, 05 Jul 2024
Nephro Care IPO LISTING GAINS
| Issue Price (adjusted) | 90.0 |
| Listing Open Price | 171.0 |
| Listing Close Price | 179.6 |
| Listing Gain% | 90.0% |
| Current Gain% | -15.8% |
Nephro Care Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nephro Care India Ltd. | 75.8 | 125 | 37.1 | -5 | 1.4 | 5.9 | 4.6 | 90.3 | 89.8 | 3.4 | -7.4 | 2 | -7.4 |
| Apollo Hospitals Enterprise Ltd. | 8945 | 128615.4 | 66.2 | 1.9 | 5.1 | 20.5 | 8.7 | 25420.1 | 15.6 | 1941.7 | 34.3 | 135 | 34.3 |
| Max Healthcare Institute Ltd. | 1070 | 104140.3 | 72.2 | 2.1 | 12.4 | 13.4 | 8.4 | 8536.1 | 18.8 | 1442.4 | 34.1 | 14.8 | 34.1 |
| Manipal Health Enterprises Ltd. | 678 | 89176 | 10.6 | 3.6 | 10520.5 | 25.8 | 892.3 | -16.2 | |||||
| Fortis Healthcare Ltd. | 955.2 | 72109.8 | 68.8 | 3.3 | 7.6 | 10.5 | 6.5 | 9178.5 | 16.9 | 1041.8 | 34.6 | 13.9 | 20.7 |
| Aster DM Quality Care Ltd. | 869.7 | 45061 | 141.4 | 882.1 | 9.2 | 8.5 | 4.8 | 4768.8 | 11.2 | 388.1 | -92.8 | 6.2 | 0.2 |
Nephro Care INFORMATION ON IPO ISSUE
About Nephro Care
Nephro Care India was incorporated on July 8, 2014. The company was founded with the objective of providing comprehensive medical services for renal patients. Based in Kolkata, it is a one-stop treatment center offering a wide range of clinical and lifestyle solutions and services for renal insufficiency treatment.
Object of the Issue
- Setting up a multi-speciality hospital in the name of Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal
- General corporate expenses
Nephro Care - PROMOTERS
| Name |
|---|
| Pratim Sengupta |
Nephro Care Lead Manager to the Issue
Corporate Capital Ventures Private Limited
smeipo@ccvindia.com
Nephro Care Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Nephro Care Strengths
Wide range of services
The services offered by the company are patient-centric and cover a wide range of patient needs that are not addressed in most daycare setups. It operates on a multidimensional patient engagement framework comprising multiple programs and facilities
Technology backbone
The company's technology backbone is robust and supports consistent improvements in the quality and efficiency of its service delivery
Focus on clinical research
The company is focused on clinical research. Its clinical research facility is supported by a dynamic and dedicated medical research team committed to advancing knowledge and innovation in the field of nephrology
Nephro Care Risks
Geographically concentrated
The company's revenues are significantly dependent on its flagship Salt Lake clinic. Further, all its clinics are located in the Kolkata
Faces competition
The company faces competition from other healthcare service providers and an inability to compete effectively could adversely affect the business, financial condition, and results of operations.
Uncertain regulations
Pricing regulations and related government reforms in the healthcare industry and associated uncertainty may adversely affect the business, financial condition, and results of operations
IPO FAQs
The promoter of the company is Pratim Sengupta.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 85.0 - 90.0.
The IPO application opens on Jun 28, 2024 and closes on Jul 02, 2024.
The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.
For all category investors, the minimum application amount for this IPO is Rs. 136,000.0, the maximum value for this IPO is Rs 144,000.0.
This IPO will be allotted on Jul 03, 2024.
The refund will be credited to your account on Jul 04, 2024.
The allotted shares will be credited to your demat on Jul 04, 2024.
Nephro Care India Ltd.’s shares listed on the stock exchanges on Jul 05, 2024.